109 results
Page 5 of 6
8-K
EX-1.1
c1jq8141s
28 Mar 19
Moleculin Announces Proposed Underwritten Public Offering
6:18am
424B5
wega9 jqrxk0h
26 Mar 19
Prospectus supplement for primary offering
5:25pm
8-K
EX-99.1
z32f0ittwk5t00y3
5 Feb 19
Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug
4:26pm
8-K
EX-99.1
slxn7 gc61z33qcv
13 Nov 18
Results of Operations and Financial Condition
7:31am
8-K
EX-10.1
z4vlwii
5 Oct 18
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
y8y28ep
13 Aug 18
Results of Operations and Financial Condition
7:24am
S-8 POS
EX-4.3
rznew6nlnr pqe7lm
27 Jun 18
Registration of securities for employees (post-effective amendment)
4:30pm
S-8
EX-4.3
snc8z1nv 04t
25 Jun 18
Registration of securities for employees
4:30pm
8-K
EX-10.1
yhjwhu
21 Jun 18
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-1.1
t9ray5 870f0iz2fj1f
21 Jun 18
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-4.1
qsa zlbmodek3fkb
21 Jun 18
Entry into a Material Definitive Agreement
4:36pm
424B5
9p1tihuvlz2z2
21 Jun 18
Prospectus supplement for primary offering
4:31pm